In its last-issued guidance in October 2016, the WHO had restricted usage to the breakthrough drug owing to concerns around its effect on the heart (cardio-toxicity).from Industry-The Economic Times https://ift.tt/2MVQCuA
In its last-issued guidance in October 2016, the WHO had restricted usage to the breakthrough drug owing to concerns around its effect on the heart (cardio-toxicity).from Industry-The Economic Times https://ift.tt/2MVQCuA
No comments:
Post a Comment